Ingalls & Snyder LLC’s Omega Healthcare OHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $290K | Hold |
6,621
| – | – | 0.01% | 374 |
|
|
2025
Q4 | $294K | Hold |
6,621
| – | – | 0.01% | 374 |
|
|
2025
Q3 | $280K | Hold |
6,621
| – | – | 0.01% | 397 |
|
|
2025
Q2 | $243K | Buy |
6,621
+50
| +0.8% | +$1.86K | 0.01% | 399 |
|
|
2025
Q1 | $250K | Hold |
6,571
| – | – | 0.01% | 389 |
|
|
2024
Q4 | $249K | Sell |
6,571
-1,075
| -14% | -$43K | 0.01% | 383 |
|
|
2024
Q3 | $311K | Hold |
7,646
| – | – | 0.01% | 363 |
|
|
2024
Q2 | $262K | Hold |
7,646
| – | – | 0.01% | 357 |
|
|
2024
Q1 | $242K | Hold |
7,646
| – | – | 0.01% | 381 |
|
|
2023
Q4 | $234K | Hold |
7,646
| – | – | 0.01% | 377 |
|
|
2023
Q3 | $254K | Sell |
7,646
-250
| -3% | -$7.99K | 0.01% | 372 |
|
|
2023
Q2 | $242K | Hold |
7,896
| – | – | 0.01% | 379 |
|
|
2023
Q1 | $216K | Hold |
7,896
| – | – | 0.01% | 386 |
|
|
2022
Q4 | $221K | Sell |
7,896
-545
| -6% | -$16.4K | 0.01% | 388 |
|
|
2022
Q3 | $249K | Sell |
8,441
-276
| -3% | -$8.65K | 0.01% | 358 |
|
|
2022
Q2 | $246K | Sell |
8,717
-3
| -0% | -$85 | 0.01% | 377 |
|
|
2022
Q1 | $272K | Hold |
8,720
| – | – | 0.01% | 391 |
|
|
2021
Q4 | $258K | Sell |
8,720
-1,300
| -13% | -$38K | 0.01% | 406 |
|
|
2021
Q3 | $300K | Sell |
10,020
-150
| -1% | -$5.16K | 0.01% | 383 |
|
|
2021
Q2 | $369K | Sell |
10,170
-35
| -0.3% | -$1.3K | 0.02% | 358 |
|
|
2021
Q1 | $374K | Hold |
10,205
| – | – | 0.02% | 325 |
|
|
2020
Q4 | $371K | Sell |
10,205
-1,800
| -15% | -$61K | 0.02% | 315 |
|
|
2020
Q3 | $359K | Sell |
12,005
-3,100
| -21% | -$96.8K | 0.02% | 273 |
|
|
2020
Q2 | $449K | Sell |
15,105
-1,750
| -10% | -$51.8K | 0.03% | 268 |
|
|
2020
Q1 | $447K | Sell |
16,855
-1,500
| -8% | -$56.9K | 0.03% | 270 |
|
|
2019
Q4 | $777K | Sell |
18,355
-1,000
| -5% | -$42.3K | 0.04% | 221 |
|
|
2019
Q3 | $809K | Sell |
19,355
-805
| -4% | -$31.4K | 0.04% | 238 |
|
|
2019
Q2 | $741K | Buy |
20,160
+1,000
| +5% | +$36.5K | 0.04% | 250 |
|
|
2019
Q1 | $731K | Hold |
19,160
| – | – | 0.03% | 243 |
|
|
2018
Q4 | $673K | Sell |
19,160
-13,000
| -40% | -$451K | 0.04% | 246 |
|
|
2018
Q3 | $1.05M | Sell |
32,160
-1,000
| -3% | -$31.8K | 0.04% | 227 |
|
|
2018
Q2 | $1.03M | Sell |
33,160
-500
| -1% | -$14.3K | 0.05% | 203 |
|
|
2018
Q1 | $910K | Sell |
33,660
-8,050
| -19% | -$215K | 0.04% | 213 |
|
|
2017
Q4 | $1.15M | Sell |
41,710
-12,200
| -23% | -$352K | 0.05% | 197 |
|
|
2017
Q3 | $1.72M | Sell |
53,910
-6,200
| -10% | -$199K | 0.09% | 150 |
|
|
2017
Q2 | $1.99M | Buy |
60,110
+4,000
| +7% | +$132K | 0.11% | 129 |
|
|
2017
Q1 | $1.85M | Buy |
56,110
+2,774
| +5% | +$89.1K | 0.1% | 144 |
|
|
2016
Q4 | $1.67M | Sell |
53,336
-13,950
| -21% | -$431K | 0.09% | 151 |
|
|
2016
Q3 | $2.38M | Buy |
67,286
+18,715
| +39% | +$665K | 0.13% | 119 |
|
|
2016
Q2 | $1.65M | Buy |
48,571
+7,260
| +18% | +$242K | 0.1% | 149 |
|
|
2016
Q1 | $1.46M | Buy |
41,311
+9,900
| +32% | +$324K | 0.09% | 143 |
|
|
2015
Q4 | $1.1M | Sell |
31,411
-3,850
| -11% | -$133K | 0.07% | 164 |
|
|
2015
Q3 | $1.24M | Buy |
35,261
+1,750
| +5% | +$61.5K | 0.08% | 152 |
|
|
2015
Q2 | $1.15M | Buy |
33,511
+11,650
| +53% | +$428K | 0.06% | 167 |
|
|
2015
Q1 | $886K | Buy |
21,861
+14,461
| +195% | +$599K | 0.05% | 186 |
|
|
2014
Q4 | $289K | Buy |
+7,400
| New | +$280K | 0.02% | 295 |
|
Other funds holding OHI
VPM
VCM
Ingalls & Snyder LLC's OHI Position: Q1 2026 in Review
Ingalls & Snyder LLC held its Omega Healthcare (OHI) position steady in Q1 2026 at 6,621 shares worth $290K. The position accounts for 0.01% of the portfolio, ranked #374.
Ingalls & Snyder LLC first reported a position in OHI in Q4 2014 and has held it in 46 quarters since. The position peaked at $2.38M in Q3 2016. 740 funds tracked by Wall St. Rank hold OHI as of Q1 2026.
- Ingalls & Snyder LLC held 6,621 shares of Omega Healthcare worth $290K as of Q1 2026.
- Ingalls & Snyder LLC left its Omega Healthcare share count unchanged in Q1 2026.
- Omega Healthcare made up 0.01% of Ingalls & Snyder LLC's portfolio in Q1 2026, its #374 holding.
- Ingalls & Snyder LLC first reported a position in Omega Healthcare in Q4 2014 and has held it in 46 quarters since.
- Ingalls & Snyder LLC's Omega Healthcare position peaked at $2.38M in Q3 2016.
- 740 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.
Based on Ingalls & Snyder LLC's 13F filing for Q1 2026, filed 13 May 2026.